| Literature DB >> 33526994 |
Aiman Saleh A Mohammed1,2, Muhammad Naveed1, Norbert Jost1,3.
Abstract
Polysaccharides are essential macromolecules which almost exist in all living forms, and have important biological functions, they are getting more attention because they exhibit a wide range of biological and pharmacological activities, such as anti-tumour, immunomodulatory, antimicrobial, antioxidant, anticoagulant, antidiabetic, antiviral, and hypoglycemia activities, making them one of the most promising candidates in biomedical and pharmaceutical fields. Polysaccharides can be obtained from many different sources, such as plants, microorganisms, algae, and animals. Due to their physicochemical properties, they are susceptible to physical and chemical modifications leading to enhanced properties, which is the basic concept for their diverse applications in biomedical and pharmaceutical fields. In this review, we will give insight into the most recent updated applications of polysaccharides and their potentialities as alternatives for traditional and conventional therapies. Challenges and limitations for polysaccharides in pharmaceutical utilities are discussed as well.Entities:
Keywords: Biological activities; Carbohydrates; Future prospects; Pharmacological applications; Polysaccharides
Year: 2021 PMID: 33526994 PMCID: PMC7838237 DOI: 10.1007/s10924-021-02052-2
Source DB: PubMed Journal: J Polym Environ ISSN: 1566-2543 Impact factor: 3.667
Fig. 1Examples of polysaccharides from different sources
Fig. 2Major macromolecules founded in the body with its precursors
Fig. 3Branched and unbranched homopolysaccharides and heteropolysaccharides, different monosaccharides represented by different colors
Fig. 4Classification of polysaccharides according to the type of monosaccharides building blocks and their physiological properties
Commercially available polysaccharides drugs with their sources [23]
| Source | Polysaccharides | Available drugs | Biological activity and application with references |
|---|---|---|---|
| Animal | Heparin | Heparin sodium cream; heparin sodium lozenge; low molecular weight heparin sodium gel; heparin calcium for injection; heparin (sodium, calcium) injection | Anticoagulant, antiviral [ |
| Chondroitin sulfate | Chondroitin sulfate tablets; chondroitin sulfate (chondroitin sulfate A sodium) capsules; chondroitin sulfate (chondroitin sulfate A sodium) injection | Coatings [ | |
| Hyaluronic acid | Sodium hyaluronate injection; sodium hyaluronate eye drops | Drug carriers [ | |
| Plant | Astragalus PS | Astragalus polysaccharide injection (2-(chloromethyl)-4-(4-nitrophenyl)-1,3-thiazole) | Immunoregulatory [ |
| Ginseng PS | Ginseng polysaccharide injections | Immunostimulant [ | |
| Fucoidan PS | Active pharmaceutical ingredient | Cell proliferation and differentiation [ | |
| Microbial | Lentinan PS | Lentinan injection; lentinan capsules; lentinus edodes mycelia polysaccharides tablets | Immunologic activities [ |
| Poria PS | Poria polysaccharide oral solution capsular | Antitumor [ | |
| Capsular PS | Vi polysaccharides typhoid vaccine; pneumococcal vaccine polyvalent; group A and C meningococcal polysaccharide vaccine | Vaccines and passive antibody therapies [ | |
| Dextran | Dextran 40 glucose injection; dextran 70 eye drops; low molecule dextran | Biotechnological applications [ |
Fig. 5Chitosan-based drug delivery systems
Fig. 6Possible immune mechanism cytokines a fungus polysaccharides increased the production of IL-2, 3, 4, 6, 8, and 12, TNF-α, IFN-γ, IL-1α, and IL-1β generated from T cells. Cytokines b mushroom polysaccharides increased the production of IL-1, 2, 3, 12, TNF-α, and IFN-γ of NK cells. Cytokines c fungus polysaccharides could improve the release of IL-6 and 8, IL-1β, TNF-α, and IFN-γ from macrophages. ConA was used as a specific T cell activator, and LPS was used as a general activator of B cells, macrophages, and DCs [82]